Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
De-escalation of anti-TNF therapy in adolescents and young adults with IBD
2020-001811-26Phase 4Active
- Sponsor
- University Medical Center Groningen
- Start
- Jul 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of infliximab and adalimumab in Crohn's disease and autoimmune colitis (2 arms), sponsored by University Medical Center Groningen. Started Jul 2020; status: active.
02
Drugs
infliximabadalimumab
03
Conditions
Crohn's diseaseautoimmune colitis
Beyond the preview
Go deeper on 2020-001811-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001811-26.